Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2008

01-09-2008 | Letter to the Editor

Medical cost-offsets from psychosocial care in breast cancer

Authors: Louisa Gordon, Monika Janda

Published in: Breast Cancer Research and Treatment | Issue 1/2008

Login to get access

Excerpt

Economic evaluations of psychosocial interventions are uncommon in cancer care and this is an important area of further research [1]. Lemieux J et al. report (2006 100:183–190) an economic analysis of psychosocial group therapy in women with advanced-stage breast cancer. We would like to comment on a few issues raised in this paper. …
Literature
1.
Gordon LG, Scuffham P, Battistutta D et al (2005) A cost-effectiveness analysis of two rehabilitation support services for women with breast cancer. Breast Cancer Res Treat 94(2):123–133PubMedCrossRef
2.
Simpson S, Corney R, Fitzgerald P, Beecham J (2000) A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression. Health Technol Assess 4(36):1–83PubMed
3.
Brouwer W, Rutten F, Koopmanschap M (2001) Costing in economic evaluations. In: Drummond MF, McGuire A (eds) Economic evaluation in health care. Oxford University Press, Oxford, pp 172–214
4.
Drummond MF, Stoddard GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes, 2nd ed. Oxford University Press, Oxford
Metadata
Title
Medical cost-offsets from psychosocial care in breast cancer
Authors
Louisa Gordon
Monika Janda
Publication date
01-09-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9750-1

Other articles of this Issue 1/2008

Breast Cancer Research and Treatment 1/2008 Go to the issue

Epidemiology

Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer

Preclinical Study

Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance

Preclinical Study

Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer

Preclinical Study

A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer

Preclinical Study

MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells

Epidemiology

Association of polymorphisms of angiogenesis genes with breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits